Lynch Syndrome and Skin: A Dermatologist’s Perspective

Dana-Farber Cancer Institute

V. Nambudiri

Treatment Options for Patients With Lynch Syndrome & CRC

University of Colorado Cancer Center

C. Lieu

Risk Factors for 5-Year Post-Colonoscopy Colorectal Cancers (PCCRCs)

Thomas Imperiale

What Will Colon Cancer Screening Look Like in 10 Years?

Stanford Medicine

D. Goldenberg

Lynch Syndrome: The Past, the Present, and the Future

University of Colorado Cancer Center

P. Lynch

AI in GI: Colon Cancer Screening and Beyond

Houston Methodist

R. Schiesser

Tackling Early Onset Colorectal Cancer

Total Health

S. Kim

Updates in Management of Colon Cancer

UChicago Medicine

B. D. Shogan

Understanding Constitutional MMR Deficiency Syndrome

Dana-Farber Cancer Institute

H. Rana

Gene-Specific Risks for Lynch Syndrome: 5 Genes in 1

Dana-Farber Cancer Institute

M. Yurgelun

Immunotherapy for Lynch Syndrome Cancers

Dana-Farber Cancer Institute

L. Biller

Breakthroughs in Molecular Diagnosis in GI Tumors: A Case-Based Disc…

UChicago Medicine 12th International Clinical Cancer Genomics Conference

C. Pritchard

Exercise as a Cancer Prevention Agent: Implications for Lynch Syndro…

Dana-Farber Cancer Institute

C. Dieli-Conwrigh

Towards Precision Prevention: Vaccines in Lynch Syndrome

UChicago Medicine 12th International Clinical Cancer Genomics Conference

M. Kloor

Colorectal Surgery for Lynch Syndrome

University of Colorado Cancer Center

J. Vogel

Updates in the Management of Hereditary Colon Cancer Syndromes

Cedars Sinai

K. Reddy

Early Detection in Lynch Syndrome: Advances in Endoscopic and Non-In…

Dana-Farber Cancer Institute

J. Samadder

Colorectal Cancer Screening: When and How? When Is It No Longer Nece…

Anna Krigel

New Mechanisms of Carcinogenesis in Lynch Syndrome & Clinical Implic…

UChicago Medicine 12th International Clinical Cancer Genomics Conference

A. Ahadova

2020 Colon Cancer Prevention Guidelines: What Are the Task Force Rec…

Scripps Health

W. Coyle